THURSDAY, July 3 (HealthDay News) -- The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, maker Johnson & Johnson said Wednesday.

The injected treatment is made from "naturally sourced collagen" using tendons harvested from pigs in the United States and Australia, The Wall Street Journal quoted the company as saying.

Evolence has been available in many other nations since 2004.

In the United States, it will compete with a number of synthetic "dermal fillers," including Medicis Pharmaceutical's Restylane and Allergan's Juvederm, the newspaper said.

More information

The FDA has more about injectable wrinkle fillers and their risks.